Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edi Brogi

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
Histopathology|January 16, 2016
Phyllodes tumours of the breast: a consensus reviewBenjamin Y Tan, Geza Acs, Sophia K Apple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune ProfilingHeather L McArthur, Adi Diab, David B Page, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2026
Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge GapsEmad A Rakha, Cecily Quinn, Gelareh Farshid, et al.
Nature Communications|May 10, 2018
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C Geyer, Anqi Li, Anastasios D Papanastasiou, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Cancer Research|December 4, 2016
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear PolaritySarah Chiang, Britta Weigelt, Huei-Chi Wen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Histopathology|January 16, 2016
Phyllodes tumours of the breast: a consensus reviewBenjamin Y Tan, Geza Acs, Sophia K Apple, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2016
A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune ProfilingHeather L McArthur, Adi Diab, David B Page, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2026
Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge GapsEmad A Rakha, Cecily Quinn, Gelareh Farshid, et al.
Nature Communications|May 10, 2018
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C Geyer, Anqi Li, Anastasios D Papanastasiou, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Cancer Research|December 4, 2016
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear PolaritySarah Chiang, Britta Weigelt, Huei-Chi Wen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 30, 2025
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow CategoriesEmad A Rakha, Puay Hoon Tan, Mieke R Van Bockstal, et al.
Histopathology|April 14, 2025
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteriaPuay Hoon Tan, Ian O Ellis, Kimberly H Allison, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2025
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further ManagementEmad A Rakha, Cecily Quinn, Wendy Raymond, et al.
Pageof 22